Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 100 of 196 entries
View as:

Interaction Between High Dose Rifampicine and Efavirenz in Pulmonary Tuberculosis and HIV Co-infection

Phase: N/A Priority: Normal
NCT ID: NCT01986543 Org: User:
Start: 12/31/13 End: 12/31/17 Due: 12/31/18

Combined Prevention of Sexually Transmitted Infections (STIs) in Men Who Have Sex With Men and Using Oral Tenofovir Disoproxil Fumarate/ Emtricitabine (TDF/FTC) for HIV Pre-Exposure Prophylaxis (PrEP)

Phase: N/A Priority: Normal
NCT ID: NCT04597424 Org: User:
Start: 01/19/21 End: 04/19/24 Due: 04/19/25

Evaluation of Raltegravir Plus Maraviroc Therapy in Controlled HIV Patients Presenting With Lipohypertrophy

Phase: N/A Priority: Normal
NCT ID: NCT01420523 Org: User:
Start: 12/31/11 End: 04/30/13 Due: 04/30/14

Efficacy of Tenofovir Disoproxil on Mother-to-child Transmission of HBV in Tokombéré, Cameroon in Pregnant Women

Phase: N/A Priority: Normal
NCT ID: NCT05403047 Org: User:
Start: 07/31/22 End: 10/31/25 Due: 10/31/26

Prevention of Mental Health Problems Among Persons Without Personal Housing in the Context of the COVID-19 Epidemic

Phase: N/A Priority: Normal
NCT ID: NCT05033210 Org: User:
Start: 03/01/22 End: 10/31/23 Due: 10/31/24

Interest of Ribavirin in the Maintenance Treatment of Liver Fibrosis Using Low Dose Pegylated Interferon alpha2b in Patients With Chronic Hepatitis C Non Responders to Previous Antiviral Therapy.

Phase: N/A Priority: Normal
NCT ID: NCT00323804 Org: User:
Start: 05/31/06 End: 03/31/13 Due: 03/31/14

ANRS 12406 EvvA Study

Phase: N/A Priority: Normal
NCT ID: NCT04593979 Org: User:
Start: 04/15/21 End: 01/14/22 Due: 01/14/23

Trial Comparing Three Strategies of Vaccination Against the Virus of Hepatitis B in HIV Infected Patients

Phase: N/A Priority: Normal
NCT ID: NCT00480792 Org: User:
Start: 06/30/07 End: 09/30/12 Due: 09/30/13

Study Comparing Safety and Immunogenicity of Intranasal COVID-19 Vaccine and mRNA Booster in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT06821126 Org: User:
Start: 05/31/25 End: 03/31/28 Due: 03/31/29

Co-adaptation Between Human Immunodeficiency Virus (HIV) and Cluster of Differentiation 8 (CD8) Cellular Immunity

Phase: N/A Priority: Normal
NCT ID: NCT02886416 Org: User:
Start: 08/31/16 End: 04/30/17 Due: 04/30/18

Early Identification and Treatment of Early HIV Infection in Côte d'Ivoire

Phase: N/A Priority: Normal
NCT ID: NCT01917175 Org: User:
Start: 06/30/97 End: 09/30/18 Due: 09/30/19

Physiopathology Study of the Microbiota Biodiversity of HIV Seropositive Patients

Phase: N/A Priority: Normal
NCT ID: NCT02116374 Org: User:
Start: 12/31/14 End: 06/30/16 Due: 06/30/17

On Demand Antiretroviral Pre-exposure Prophylaxis for HIV Infection in Men Who Have Sex With Men

Phase: N/A Priority: Normal
NCT ID: NCT01473472 Org: User:
Start: 01/31/12 End: 12/15/16 Due: 12/15/17

Trial Comparing Two Strategies of Vaccination Against Hepatitis B in HIV-infected Patients Non Responding to Primary Immunization (B-BOOST)

Phase: N/A Priority: Normal
NCT ID: NCT00670839 Org: User:
Start: 05/31/08 End: 02/28/13 Due: 02/28/14

Evaluation of the Immunogenicity and Safety BBIBP-CorV Vaccine for COVID-19 in Adults in Guinea

Phase: N/A Priority: Normal
NCT ID: NCT05409300 Org: User:
Start: 04/25/22 End: 02/28/25 Due: 02/28/26

"Real Life" Evaluation of Efficacy and Safety of Direct Antiviral Agents (DAAs) for the Treatment of Hepatitis C Virus in Egypt

Phase: N/A Priority: Normal
NCT ID: NCT03510637 Org: User:
Start: 01/22/18 End: 08/31/20 Due: 08/31/21

Feasibility and Effectiveness of a Pilot Program of Physical Activity to Improve HIV Related Functional Limitations and Disability in Adults Aged 40 and Older From Côte d'Ivoire

Phase: N/A Priority: Normal
NCT ID: NCT06139497 Org: User:
Start: 10/31/23 End: 04/30/24 Due: 04/30/25

Covid-19 Vaccine Cohort in Specific Populations

Phase: N/A Priority: Normal
NCT ID: NCT04824651 Org: User:
Start: 03/25/21 End: 06/25/24 Due: 06/25/25

PoC-HCV Genedrive Viral Detection Assay Validation Study

Phase: N/A Priority: Normal
NCT ID: NCT02992184 Org: User:
Start: 09/30/16 End: 12/31/16 Due: 12/31/17

Feasibility, Tolerance and Efficacy of Interferon-free, Antiviral Treatment With Sofosbuvir + Ribavirin for the Treatment of Genotype 2 and Sofosbuvir/Ledipasvir for the Treatment of Genotype 1 and 4 Hepatitis C Virus-infected Patients in West and Central Africa

Phase: N/A Priority: Normal
NCT ID: NCT02405013 Org: User:
Start: 10/31/15 End: 11/30/17 Due: 11/30/18

Epicardial Adipose Tissue And Coronary Risk In HIV-Infected Patients

Phase: N/A Priority: Normal
NCT ID: NCT01899196 Org: User:
Start: 07/31/13 End: 03/31/16 Due: 03/31/17

Pilot Study Evaluating the Impact of Delay Between Administration of Inmazeb Administration and Vaccination by Ervebo on Vaccine Immune Response on Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT05202288 Org: User:
Start: 03/31/22 End: 03/31/23 Due: 03/31/24

Raltegravir Versus Efavirenz in Naive HIV-1-infected Patients Receiving Rifampin for Active Tuberculosis

Phase: N/A Priority: Normal
NCT ID: NCT02273765 Org: User:
Start: 09/11/15 End: 11/28/18 Due: 11/28/19

OPtimisation of Antiviral Therapy in Immunocompromised COVID-19 Patients: a Randomized Factorial Controlled Strategy Trial

Phase: N/A Priority: Normal
NCT ID: NCT05587894 Org: User:
Start: 04/27/23 End: 05/31/25 Due: 05/31/26

Identification of Molecular Signatures of High-risk Oncogenic HPV and Study of Their Associations With the Presence of High-grade Lesions and/or Anal Cancer 10 Years After Inclusion in the ANRS IPERGAY Trial

Phase: N/A Priority: Normal
NCT ID: NCT06522256 Org: User:
Start: 02/06/25 End: 07/30/27 Due: 07/30/28